English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/164946
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Radioligand binding detection of receptors in brain membranes

AutorPilar-Cuéllar, Fuencisla ; Díaz, Álvaro ; Garro-Martínez, Emilio; Martín, Alicia ; Romero-Presno, Beatriz ; Valdizán, Elsa M.
Fecha de publicación2016
EditorSpringer Nature
CitaciónReceptor and Ion Channel Detection in the Brain: 59-76 (2016)
SerieMethods and Protocols 110
ResumenTransmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors, as well as the ligand affinity. Here we describe a classic way of doing this by exposing cells or tissue membranes to radiolabeled molecules (radioligands) that bind selectively to receptors in the sample (receptor binding assay). The functional consequence of the receptor occupancy or level of G-protein activation could be measured by [35S]GTPγS binding assay. This assay measures the binding of the non-hydrolyzable analogue [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits. [35S]GTPγS binding assays, also known as functional binding assays, are carried out in a similar way as radioligand (receptor) binding assays. The above radiometric assays are useful to differentiate among agonist, antagonist, and inverse agonist activities, in addition to traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity and agonist-specific G-protein-coupled signaling. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research.
URIhttp://hdl.handle.net/10261/164946
Identificadoresdoi: 10.1007/978-1-4939-3064-7_6
isbn: 978-1-4939-3063-0
Aparece en las colecciones: (IBBTEC) Libros y partes de libros
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.